Shares of Straumann Holding AG (OTCMKTS:SAUHY – Get Free Report) shot up 9.7% during trading on Thursday . The company traded as high as $12.8292 and last traded at $12.8292. 1,274 shares traded hands during mid-day trading, a decline of 99% from the average session volume of 169,923 shares. The stock had previously closed at $11.69.
Wall Street Analysts Forecast Growth
SAUHY has been the topic of several recent research reports. Morgan Stanley restated an “underweight” rating on shares of Straumann in a report on Tuesday, April 14th. Citigroup reaffirmed a “sell” rating on shares of Straumann in a report on Thursday, April 23rd. Finally, Barclays reiterated an “overweight” rating on shares of Straumann in a research report on Thursday. Two analysts have rated the stock with a Buy rating, two have issued a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold”.
Check Out Our Latest Report on Straumann
Straumann Price Performance
Straumann Company Profile
Straumann (OTCMKTS:SAUHY) is a Swiss-based dental technology company that develops, manufactures and markets restorative, regenerative and digital solutions for dental professionals. The company’s core offerings center on implant-supported restorations and components, biomaterials used for bone and soft-tissue regeneration, and a range of prosthetic products used by dentists and dental laboratories to restore oral function and aesthetics.
In addition to implant and biomaterial product lines, Straumann provides digital dentistry solutions that support treatment planning and workflows.
Featured Stories
- Five stocks we like better than Straumann
- Aehr Spikes on New Order, But Has Stock Gotten Ahead of Itself?
- Rackspace’s AI Land Grab: Plugging Into the Next Compute Boom
- Satellogic Is Tiny But Its Revenue Growth Is Hard to Ignore
- Why Kroger’s Pullback Could Be a Gift for Patient Investors
Receive News & Ratings for Straumann Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Straumann and related companies with MarketBeat.com's FREE daily email newsletter.
